Focus: Tandem Diabetes is a medical device company specializing in touchscreen insulin pumps and closed-loop diabetes management systems for Type 1 diabetes. The company is based in San Diego and operates in the metabolic disease space with a focus on connected device technology.
Profile data last refreshed 4h ago · AI intelligence enriched 1mo ago
Stable — net +4 jobs in 30d
40 added, 36 removed. Backfill posture.
A specialized medical device company with an established product franchise, but stalled hiring and thin clinical pipeline suggest limited near-term career momentum.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Tandem Diabetes
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Tandem Diabetes's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo